Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Abstract

Entities: Chemical

Source DB: PubMed Journal: J Thorac Oncol ISSN： 1556-0864 Impact factor: 15.609

× No keyword cloud information.

2 in total

1. Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer.

Authors: Pietro Di Marino; Cosima Chiapperino; Francesca Chiara Primavera; Maria Teresa Martino; Davide Brocco; Consiglia Carella; Antonino Grassadonia; Nicola Tinari; Michele De Tursi
Journal: Onco Targets Ther Date: 2022-04-11 Impact factor: 4.345

2. Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung Cancer.

Authors: Hong Jian; Kai Wang; Ying Cheng; Lieming Ding; Yang Wang; Zhe Shi; Ling Zhang; Yaolin Wang; Shun Lu
Journal: Oncologist Date: 2022-03-11

2 in total